| 000 | 01072 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250517160533.0 | ||
| 264 | 0 | _c20180312 | |
| 008 | 201803s 0 0 eng d | ||
| 022 | _a1873-2518 | ||
| 024 | 7 |
_a10.1016/j.vaccine.2017.05.090 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDuintjer Tebbens, Radboud J | |
| 245 | 0 | 0 |
_aModeling the costs and benefits of temporary recommendations for poliovirus exporting countries to vaccinate international travelers. _h[electronic resource] |
| 260 |
_bVaccine _c07 2017 |
||
| 300 |
_a3823-3833 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 | _aGlobal Health |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMedication Reconciliation _xeconomics |
| 650 | 0 | 4 |
_aPoliomyelitis _xprevention & control |
| 650 | 0 | 4 | _aTravel-Related Illness |
| 700 | 1 | _aThompson, Kimberly M | |
| 773 | 0 |
_tVaccine _gvol. 35 _gno. 31 _gp. 3823-3833 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.vaccine.2017.05.090 _zAvailable from publisher's website |
| 999 |
_c27270330 _d27270330 |
||